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1
INTRODUCTION
The biochemical basis of cellular function involves the intricate interplay
of signaling molecules, receptors, and lipid (fatty-acid) membranes. The ubiquity
of membranes, from the outer membrane that protects a eukaryotic cell to the
different membranes that surround each intracellular constituent, accentuates their
importance in cellular life. Proteins, associated with biological membranes, carry
out the majority of the biological functions of these fluid lipid bilayers and are
responsible for regulating the flow of chemical information in and out of the cell.
Membrane fluidity adds versatility to the cell by allowing its membrane surface
components to easily redistribute, to readily recognize cellular signals, and to
participate in all kinds of life-sustaining biological reactions. Because of the
specificity in evolved biochemical recognition, mimicking these functionalities in
artificial membrane systems for their application as biosensors, biochemical
reactors, drug-screening devices and hybrid-cell communication systems is
desirable [1].
Anchoring a protein to a lipid membrane is generally achieved by
modifying the protein of interest with a lipid molecule (i.e., lipidating) that can
anchor into a biomimetic lipid membrane. Efforts to capture the natural elegance
and efficiency of in vivo post-translational modifications and coordination of
these modified proteins in artificial membrane systems have been limited by both
the types of lipids that can be attached to the protein and by the location along the
protein at which lipidation can be successfully performed. These limitations can
potentially be addressed by using a recently developed “aldehyde tag”
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technology, i.e., the site-specific integration of the non-standard amino acid
formylglycine which bears a reactive aldehyde side chain for further chemical
modification [2]. This aldehyde functional group potentially opens also a versatile
avenue for synthetic protein lipidation by facilitating the site-specific covalent
attachment of lipids with aminooxy-modified head groups. The main goal of this
study is to develop a proof of principle demonstrating the successful site-specific
insertion of an aldehyde side chain to an enhanced green fluorescence protein
(EGFP) for subsequent lipidation at the aldehyde site and incorporation into a
fluid supported lipid bilayer. An EGFP was aldehyde-tagged at the carboxylterminus and covalently bonded to an aminooxy-modified phospholipid
(specifically a phosphatidylethanolamine). The successful incorporation of the
resulting aldehyde-tagged EGFP lipid anchor constructs into a solid-supported
lipid bilayer was verified by fluorescence microscopy. Fluorescence recovery
after photo-bleaching (FRAP) was used to confirm the preservation of the fluidity
of both the EGFPs and lipids in the bilayer.

BACKGROUND

1. The Biological Importance of Lipid Bilayers
The prevalence of lipid membranes in partitioning cellular function, from
the homeostatic processes across the bilayers that separate intracellular organelles
to the more complex signaling mechanisms that drive organ systems, confirms
their importance in mediating cellular life. Cells are dynamic; they communicate,
react, and constantly change their physical and chemical characteristics to ensure
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proper cell function, survival, and proliferation [3]. The chemical recognition of
both intra- and extracellular signals is one of the most important membrane-bound
membrane
biochemical processes. In many of tthese
hese processes, receptors must aggregate
around a bound antigen in order for the subsequent steps in signal transduction to
occur. For example, through a process called receptor
receptor-mediated
mediated endocytosis,
specific molecules are recognized by outer
outer-membrane proteins
eins to coordinate a
small section of a membrane to pinch off and encase the molecules, thereby
facilitating their transport between organelles and cells. Therefore, a large number
of life-sustaining
sustaining biochemical events are coordinated on and/or by the body’s
body
cellular membranes [3]. In addition, the lipid membrane protects and holds much
of the cellular machinery required for cellular commu
communication
nication and cell
maintenance [4].
Lipids are amphipathic molecules with a hydrophilic (water-loving)
(water
head
group bonded to long hydrophobic (water
(water-fearing)
fearing) fatty acid chains [Figure 1]. In
aqueous

solution

this
t

amphipathic nature allows
lipids to self-assemble
self
into
thermodynamically
ellipsoidal,

closed

stable
lipid

structures called liposomes.
The wall of such liposomes
Figure 1:: Chemical structure of a phospholipid with its
hydrophilic head and hydrophobic fatty acid chains [5].

is

a

lipid

bilayer

that

contains at least two sheets
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of lipids, one on top of the other, with the hydrophilic heads facing out, and the
hydrophobic tails facing in [Figure 2]. An important consequence of this
dynamically stable configuration is its properties as a barrier. The membrane
houses the cell’s machinery in an aqueous environment, while protecting its inner
constituents by prohibiting the
trans-membrane
membrane movement of
most

molecules

Furthermore,

and

the

ions.
bilayer

structure permits lipids and
other molecules located within
each plane of the bilayer to
move

and

across
ross

the

membrane.

diffuse laterally
plane

of

the

This

mobility

within the membrane leaflets
permits cellular mobility and

Figure 2:: The physical organization of lipids in
aqueous environments as a liposome, a micelle and in
a section of a bilayer. Hydrophilic heads
head face the
surrounding water as hydrophobic tails face each
other inside the bilayer. Liposomes are surrounded
by water and may also encapsulate an inner region of
aqueous solution [6].

the necessary dynamic rearrangement of the membrane
membrane-associated
associated proteins and
receptors that mediate cellular adhesion and the commun
communication
ication that is integral to
cellular life and applications in biotechnology [3].

2. Biomimetic Membrane Interfaces and Their Important Properties
Biological membranes serve as barriers that separate and safeguard
neighboring cells and the intracellular organelles of a cell. Their stability as
barriers allows them to partition cellular space and function by limiting the
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movement of molecules across the membrane, while allowing certain processes to
take place in different areas of the living cell. As a result, cell membranes not
only efficiently divide up cellular life, but also must closely regulate signaling
pathways, chemical gradients, and chemical trafficking among separated cellular
environments [1]. Given these properties, the reasons why much of the cell’s
important chemical activity occurs at the membrane is clear.
From the membranes that encapsulate individual organelles to the one
membrane protecting the entire cell, membranes in eukaryotic cells vary
dramatically in regard to lipid composition, organization, and the cellular
processes that take place on the surface. However regardless of a membrane’s
chemical identity, all biological membranes must be dynamic, in the
rearrangement of membrane constitutes in the plane of the membrane, in order to
effectively partake in the cell’s conformational, signaling, trafficking, and
recognition events [1]. Because of the dynamic spatial requirements for proper
membrane function, the development of biomimetic membrane systems has
progressed to help elucidate the biochemical and biophysical phenomena that take
place at the membrane interface. In addition, many simplified model membrane
systems have been created to preserve the fundamental bilayer structure and lipid
dynamics, while enabling analysis of the roles and organization of individual
membrane components [1]. Model membrane systems allow for the study of
biomembrane processes at the cellular level, providing information about
membrane properties, ligand-receptor interactions, cellular signaling events, and

6
immune responses [4, 7]. For example, supported lipid bilayers (SLBs) allow for
the easy study of membrane surface assembly, organization, and interactions [4].
Most important, because biomimetic lipid membranes may be tailored
with the same lipids that make up the eukaryotic cell, they are therefore naturally
biocompatible with living cells. Lipid-based biomembrane devices provide
biocompatible surfaces that work in the human body and its cells. This is
exemplified in the current developments of membrane-based technologies such as
biosensors, biochemical reactors, drug-screening devices, clinical imaging
nanostructures, drug/gene delivery systems and hybrid-cell communication
systems [1,8,9]. Biosensors, such as on-chip immunoassays, which measure the
kinetics and thermodynamics of antibody binding to membrane antigens, serve as
an example of the powerful sensor applications of biomimetic lipid surfaces [4].
In medical applications, liposomal anticancer drugs have proven to be a
successful alternative treatment for tumors [10]. Hydrophilic head groups of the
inner membrane leaflet enclose the hydrophilic drug (like attracts like) to form a
liposome around the drug [4]. Then, the drug is delivered to the tumor, using
antibodies or ligands that are mounted on the liposome’s outer surface, and are
specific for antigens on the tumor cell surfaces [4]. Finally, the drug-containing
liposome fuses with the tumor’s cell membrane and enters the cell by receptormediated endocytosis to deposit the drug.
Most, if not all, of these applications require specific proteins that
functionalize the bilayer, allowing the membrane to take part in biochemical
interactions. Similarly, in the body, proteins mediate the exchange of chemical
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signals between the cellular organelles and the cell’s external environment
through channel proteins, receptor proteins, and antibodies. Because of the high
level of specificity of biochemical processes, biomimetic lipid interfaces must be
developed using proteins that can dynamically reorganize within the bilayer [3].
When interfacing with a live eukaryotic cell, for example, biomimetic membranebound proteins should be able to follow the movement of their binding partners
on the cell surface; e.g., the dimerization, or general oligiomerization, of protein
receptors that is often essential to create the proper signal. There are many
chemical identification processes that require protein receptors to aggregate and
localize at the site of the chemical signal in order to ensure that the signal gets
transported across the membrane [11].
There is one more feature of a biological membrane that is difficult to
replicate in biomimetic membrane models: the ability to phase separate (i.e., to
alter its lipid organization), depending on its lipid composition. Phase separation
in a bilayer, depends on the amount of the different types of lipids present, which
may include glycophospholipids with saturated and unsaturated fatty acid chains,
cholesterol, and sphingomyelin. During a separation event, different membrane
components take on different configurations [Figure 3]. Coupling this membrane
property with protein anchoring will further allow biomimetic protein-lipid
systems to actively rearrange themselves, leading to the formation of large-scale
dynamic structures of proteins that depend on what types of lipids the proteins are
attached to on the biomimetic membrane [8]. For these reasons, it is imperative
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that surface membrane proteins be anchored onto the bilayer in a fashion that
preserves their overall function and motility.

Figure 3: A schematic overview of phase separation. By raising and lowering the temperature
to be above or below the transition temperature, Tm, the lipids will redistribute across the
membrane (i.e., phase separate) according to their chemical identity. In the above image, the
bilayer contains two types of lipids: one labeled red and the other black.

3. Solid-Supported Lipid Bilayer Systems
Solid-supported lipid bilayers (SLBs) are stable membrane models that
support a variety of surface analysis techniques for studying membrane surface
function and assembly. There are a limited variety of surfaces that can support a
high quality membrane (i.e., one with little to no defects with high lipid mobility)
because substrates need to be hydrophilic, smooth, and clean [11]. SLBs have
been deposited on silicon oxide, borosilicate glass, mica, and silicon substrates
[11]. Most important, the optical clarity of glass and silicon substrates allows for
the easy access of the SLB’s structure with various microscopy techniques.
Through a process called vesicle fusion, small unilamellar vesicles (SUVs)
fuse into an enlarged vesicle before they rupture into a planar fluid bilayer on the
substrate [Figure 4] [12]. With the help of intermolecular forces, the smaller
vesicles fuse with each other until a critical size is reached, at which point the
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internal

tension

of

the

vesicle’s

curvature, reaches a point where the
continued fusion of SUVs, causes the
large vesicle to rupture into two leaflets
of lipid
d membrane that settle onto the
solid substrate [Figure 4 and 5] [12].
Intermolecular

forces

–

such

as

electrostatic forces, van der Waals
Figure 4: Vesicle Fusion Process: SUVs
fuse into a large vesicle before rupturing
onto a slid surface to fo
form a supported lipid
bilayer. [12].

interactions,

and

hydration

forces

between the lower leaflet of the

supported lipid bilayer and the substrate enable the membran
membranee to remain stable
[4]. The fluid-supported
supported bilayer rests on a 10-20Å
20Å layer of water, which is trapped
between the bilayer and th
the glass substrate [Figure 5] [11].
]. This layer of water
serves to keep the lipids in both sheets of the membrane fluid [4].
[4 Once the
membrane is formed, it must be constantly kept in aqueo
aqueous
us solution as the
hydrophobic and hydrophilic interactions and intermolecular forces stabilize the
lipid bilayer structures. If the sample dries, the bilayer will fall apart. Generally,
buffer solutions at a pH and with ionic conditions that mirror the in vivo
environment of the eukaryotic cell (pH ~7.5 with ~120mM of NaCl) are
appropriate for ensuing deposition of proteins onto the SLB surface. Besides the
widely used vesicle fusion techniques, SLBs have also been deposited onto
substrates one lipid monol
monolayer (i.e., lipid leaflet) at a time onto substrates using
the Langmuir-Blodgett
Blodgett and Langmuir
Langmuir-Schaefer techniques [11].
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Figure 5:: Diagram of a solidsolid
supported lipid bilayer. Of note is
that the water molecules surround
the bilayer from above and below,
thus
supporting
the
lipids’
membrane configuration.
configuration The solidsupported lipid bilayer maintains its
fluidity by resting on a 10-20Å layer
of water, which is trapped between
the bilayer
ayer and the glass substrate
[11].

Supported Lipid Bilayers
4. Anchoring Proteins onto Supp
Attaching proteins to a fluid lipid membrane may be achieved by protein
lipidation to (or acyl chain modification of) lipid anchors and by the addition of
hydrophobic protein anchors that are made of selected amino acids [13].
[
The
latter
ter method requires a hydrophobic environment for the stable production of
proteinaceous membrane anchors, and therefore, it is difficult to carry out and
maintain in vitro [13]. Current lipidation methods for integrating proteins into
fluid artificial bio
biomembranes employ either a glycosylphosphatidylinositol
tidylinositol (GPI)
anchor, a His-tag
tag + nickel linkage, or a biotin + streptavidin binding. Each of
these techniques has drawbacks that limit control over where and how a protein is
positioned on the membrane, what type of lipids the protein may attach to, and at
what positions the attachment can take place.
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Naturally occurring GPI anchors are actively used in eukaryotic cells,
covalently attaching modified proteins to the extracellular side of the cell
membrane [14].
]. The GPI lipi
lipidation
dation method has positioning limitations that allow
GPI anchors to attach only at the protein’s carboxyl terminus [Figure 6] [14].
Thus,

the

GPI anchor

motif severely restricts the
possible orientations of a
protein incorporated on the
membrane

surface.

Furthermore, the chemical
identities

of

the

two

resulting lipid anchors are
fixed

by

a

postpost

translational modification
Figure 6: A diagram of a gglycosylphoshaptidylinositol
(GPI) anchor [15].. A GPI anchor contains a sugar region
(the glycan core that is made up of mannose and glucose
molecules) that binds the protein to the fatty acid or acyl
chains.

mechanism
eukaryotic

in

the

cell’s

Golgi

apparatus, thereby limiting

the types of supported lipid bilayer compositions that may be constructed.
constr
An in
vitro synthesis of the GPI anchors would permit the choice of acyl chain
modification, but the chemical pro
production
duction of GPI is complicated [16].
[16
The His-tag
tag method involves an inserted polyhistidine sequence (6-12
(6
Histidine
tidine residues
residues) at the protein’s
ein’s C or N terminus, which is used to bind to
nickel (Ni) atoms present on lipid head groups at the membrane surface [Figure
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7]. The His-tag procedure involves a carboxyl or amino terminus bound
polyhistidine chain that binds nickel atoms on the surface of a membrane [17].
Currently, only one phospholipid with a nickelated head group is commercially
available, once again limiting the variety of lipid membrane compositions. The
histidine + nickel interaction is also reversible and thus the amount of bound
protein is highly sensitive to changes in pH, temperature, and time [17]. Finally,
histidine + nickel binding is ill-defined, due to the His-tags possibly interacting
with up to two nickel head groups and the reversible nature of this His + Ni
interaction on the membrane surface [Figure 7].

Figure 7: Histidine Tag + Nickel Method: Green fluorescence proteins (GFP) were modified
with a polyhistidine tag (containing 10 His residues) at the carboxyl or amino terminus. Histagged GFPs may bind up to two nickel atoms located on the membrane surface. Binding is
reversible as indicated by the arrows. In the figure, lipids with nickelated head groups are
labeled in orange [17].

The biotin-streptavidin method utilizes proteins and lipids that are
biotinylated to bind with streptavidin, a molecule that acts as a “glue” that links
up to four biotinylated constructs [Figure 8]. However, biotinylation of particular
amino acid side-groups may occur at multiple regions along the protein, resulting
in a non-site specific binding with streptavidin and consequently, non-specific
lipid attachment [18]. Furthermore, streptavidin at elevated surface concentrations
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Figure 8:: Biotin + streptavidin m
method: Proteins (balloon-shaped)
shaped) containing a biotin (upside(upside
down T shaped anchor) bind with streptavidin found on the membrane surface. As seen in the
diagram, streptavidin is attached to the membrane via linkages with biotinylated lipids on the
surface. Currently, the variety of biotinylated lipids that are commercially available is limited.

forms large-scale
scale aggregates that impede the lateral motion of the lipid-bound
lipid
proteins and prohibits the dep
deposition
osition of large amounts of protein [18]. Thus,
biotin-streptavidin
streptavidin binding is difficult to predict, measure, and control. Also, the
commercial availability of biotinylated lipid anchors is limited.
In summary, both the His + nickel and biotin + streptavidin approaches
have been proved to successfully attach prot
proteins
eins onto the membrane surface.
However, in addition to the lim
limitations
itations of, and the problems regarding, the choice
of commercially available lipid anchors and the possible sites of protein lipidation
(i.e., the use of only the C and N terminus in His tag modification and the random
biotinylation of proteins)
proteins), both methods
hods are faced with problems of dynamic
consistency in protein attachment
attachment,, competitive binding for single substrates,
substrates and
the specificity of modified lipids for binding. These constraints prohibit the
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exploitation of all the dynamic physicochemical properties of biomimetic
membranes. Thus, there is a need to develop a new method that allows the
freedom to choose from a large variety of lipid anchors and to attach them at
virtually any location along a protein.

5. The Aldehyde Tag
To meet this need and to overcome the limitations of current
methodologies described above, the aldehyde tag offers a new approach to protein
attachment that permits proteins to bind at well-defined positions with one of
many different lipid anchor motifs. It was recently found that the site-specific
insertion of a six-amino-acid consensus sequence (LCTPSR) into a protein’s
amino acid chain is sufficient to target the cysteine within the hexapeptide for a
post-translational modification by a formylglycine-generating enzyme (FGE)
[19]. This consensus sequence, also known as the “sulfatase sequence,” along
with FGEs, occurs naturally in eukaryotic organisms and plays a vital role in
activating the catalytic function of sulfatases, which are enzymes that hydrolyze
sulfate esters in the cell [20].
While there are a variety of protein modifications, few offer the sitespecificity that is guaranteed by this consensus motif. In addition, the consensus
sequence’s relatively small size minimizes the structural effects that would
destabilize the protein’s structure. As seen in Figure 8, the FGE recognizes and
acts specifically on this consensus motif and oxidizes the cysteine into a
formylglycine, which provides a reactive aldehyde group for chemoselective
reactions with aldehyde-specific reagents that include: aminooxy- (-ONH2) and
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hydrazide-modified
modified molecules [20
[20].
]. The aldehyde side chain binds covalently
with these reagents to produce very stable linkages. Of great benefit is the fact
that the consensus sequence may be inse
inserted
rted into any site along a polypeptide
chain, allowing for site-specific protein modification with high chemical
accuracy, such as the covalent attachment of aminooxy
aminooxy-modified
modified lipids to the
aldehyde tag [Figure 9]. As a result, the aldehyde tag provides the
th site-specificity
and precise chemical control that is necessary to produce post-translational
post

Figure 8:: The consensus sequence L
LCTPSR
TPSR is inserted anywhere along a protein’s amino acid
chain. A FGE will read only this consensus sequence and translate the cysteine to a
formylglycine,, thus site
site-specifically
specifically introducing a reactive aldehyde side chain.

Figure 9:: A diagram of the aldehyde tagging procedure. The conversion of the cysteine (C) to
a formylglycine (FGly) generates a reactive aldehyde side chain for subsequent chemical
coupling to an aminooxy
aminooxy-modified partner (e.g., the chemical label).
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modifications on any type of protein and anywhere along its peptide chain.
6. The Enhanced Green Fluorescence Protein (EGFP)
A naturally occurring protein that is found in a variety of aquatic life,
Green Fluorescent Protein (GFP), emits a green light when excited by blue light
and has become a well-established fluorescence marker in biological cell studies
[21]. The discovery of GFP and its derivatives such as the more photo-stable
Enhanced Green Fluorescent Protein (EGFP) has revolutionized molecular
imaging with its easy application and diverse uses [21]. A potent advantage of this
protein is the ability of the EGFP gene to be easily integrated into virtually any
part of a protein’s DNA sequence and to be translated into a functional
fluorophore, an excitable light-emitting structure, within its final protein structure.
EGFP allows for the quantitative measurement of successful protein-lipid
anchor integration. Since EGFP detection is straightforward using fluorescence
microscopy, it is the perfect protein for testing the aldehyde tag-based lipidation
of proteins. By measuring the green fluorescence, a quantitative measurement of
our GFP-lipid anchor’s abundance across the supported lipid membrane can be
achieved.

7. Fluorescence Microscopy
Fluorophores are essential to fluorescence microscopy and have been
widely used in microbiology to tag and identify, with high accuracy, cells and
their intracellular constituents. By using multiple fluorophores of different colors,
various structures of the cell may be simultaneously imaged [22]. Fluorophores
are molecules that emit light at defined wavelengths after they have been excited
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with excitation light at shorter wavelengths [22].
]. Currently, there is a wide variety
of synthetic and naturally occurring fluorophores available, each with their
specific chemical target and tagging procedure [22].
A fluorescent microscope simultaneously irradiates excitation photons and
collects the photons emitted by the fluorophores. This is done with the help of
special filters that can separate the excitation and emission wavelengths of the
fluorophores and project the emitted light onto the eyes or detector [Figure 10a].

(a)

(b)

Figure 10: (a) Separation of excitation and emission light with special band filters. Notice how
photons
ns hit the specimen and radiate spherically in all directions. The filters collect and
separate only a portion of these spherical light waves [23]. (b) Filter cube containing the
excitation filter, the fluorescence emission filter, and the dichromatic
hromatic mirror [22].
[22

First, photons at different wavelengths pass through an excitation filter, which
picks out the desired wavelengths of light to excite the fluorophores. Next, the
selected excitation photons reflect off the surface of a dichromatic (also called a
dichroic) mirror and travel to the specimen [Figure 10b and 11]. The excited
fluorophores on the specimen will emit light throug
through
h an objective lens, then hit
the dichroic mirror, and pass an emission filter (at the top of a filter cube) that
only allows the emission photons to pass through and project an image of only the
fluorophores on the specimen [Figure 11] [22
[22].
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Figure 11:
chematic overview of a
A schematic
fluorescence microscope [24
[24].
Excitation photons are emitted
from a mercury or xenon arc
lamp to excite fluorophores on
the sample. A dichroic mirror or
beam splitter separates the
excitation photons from the
fluorophores’ emission
ssion photons
allowing the detector to collect
only the fluorophores emitted
photons. An objective lens is
used to magnify the specimen.

8. Fluorescence Recovery After Photo
Photo-Bleaching (FRAP)
Photo-bleaching
bleaching results in the irreversible break down of excited
fluorophores when they react with oxygen right before they emit light.
Fluorescence recovery after photo
photo-bleaching
bleaching (FRAP) exploits this phenomenon to
examine the diffusion of tagged biologic
biological molecules on the specimen [22].
[22 In this
process a region of the specimen is exposed to excitation light, which
subsequently permanently bleaches (i.e. deactivates) the fluorophores. Bleached
fluorophores have their chemical structure permanently disrupted, so that they
th
may no longer undergo the conformational changes that are necessary for their
fluorescence activity. By observing the rates and patterns in fluorescence recovery
in the bleached region over a period of time, the motion of the tagged molecules
may be determined
ermined [22
[22].
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MATERIALS AND METHODS

1. Preparation of EGFPs with the Aldehyde Tag
The aldehyde tag’s consensus sequence was fused to the carboxyl
terminus of an enhanced green fluorescence protein (EGFP). All of the EGFPs
were expressed in and extracted from an E. Coli system. In addition, to improve
the yield of aldehyde production after EGFP translation, the consensus sequenceEGFP fusion construct was co-expressed with the DNA sequence for a
formylglycine-generating enzyme (FGE). FGEs specifically target the six-aminoacid sequence to enzymatically convert the cysteine in the consensus sequence
into a formylglycine (FGly), leading to the site-specific introduction of an
aldehyde side chain for further chemical modification [Figure 12]. Next, the
EGFP’s aldehyde group was reacted with commercially available phospholipid
anchor motifs that were previously modified to bear an aminooxy reactive head
group [For details see Appendix A].

2. Aminooxy-Modification of Commercially Available Phospholipids
Commercially available phosphatidylethanolamine (PE) phospholipids
were aminooxy-modified to bear the (-ONH2) required to covalently react with
the modified-EGFP’s aldehyde side chain [Figure 12 and Appendix A]. PE
phospholipids with different acyl chains (or fatty acid chains) are available at
Avanti Polar Lipids. The coupling of the aminooxy- group to the lipid required an
initial reaction with a Boc-protected aminooxy-reagent, followed by bocdeprotection to form the aminooxy-modified lipid product.
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Overview of Aldehyde-Tagged EGFP + Aminooxy-Lipid Anchor Preparation
(a)

(b)
Figure 12:
A schematic of the aldehyde-tagging and
lipidation process:
(a) The consensus sequence (LCTPXR) was
inserted at the EGFP’s C-terminus. Coexpression with FGE on the same plasmid yields
the site-specific introduction of the aldehyde
side chain for reaction with aldehyde-specific
binding partners (e.g., aminooxy-modified
lipids).
(b) Chemical reaction between an aldehyde
tagged-EGFP and aminooxy- (ONH2)-lipid
(phosphatidylserine) forms a stable covalently
bonded
protein-lipid
anchor.
Different
phosphatidylethanolamine (PE) phospholipids
of varying structure and acyl-chain (tail)
compositions may be lipidated on an aldehydetagged protein.
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Boc groups are often used in chemical reactions to protect amine groups from
reacting until they are needed. Therefore, first, Boc -2- (aminooxy) acetic acid
was added to a 3-neck flask. The flask was evacuated and filled with argon. Next,
dry methylenechoride (CH2Cl2) and carbonyldiamidazole (CDI) were added to the
flask. The solution was left to stir for 30 minutes to allow the activation of the
carboxylic acid group. Next, the PE phospholipid was added to the reaction and
allowed to stir overnight at room temperature, ~25°C to facilitate coupling.
Afterwards, the reaction intermediates were washed with 1M hydrochloric acid
(HCl) and brine (salt water). The organic layer was then dried over magnesium
sulfate (MgSO4), and filtered, and the remaining solvent was evaporated to yield
the boc-protected lipid [Appendix A]. Next, the modified lipids were dissolved in
1:1 CH2Cl2: TFA (Trifluoroacetic acid) and allowed to stir for 2 hours. To remove
the boc- group, TFA and CH2Cl2 were evaporated to generate the deprotected
aminooxy-modified lipid for the subsequent reaction with an aldehyde-tagged
EGFP. Due to the presence of residual TFA at the end of the reaction, 4M HCl in
dioxane will be substituted in future coupling reactions.

3. Preparation of Small Unilamellar Vesicles (SUVs) for Supported Lipid
Bilayer (SLB) Formation
Small unilamellar vesicles (SUVs) consisting of two molar percent Marina
Blue® 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (a lipid with a
blue fluorophore attached to its head group) and 98 molar percent 1,2-dioleoyl-snglycero-3-phosphocholine (DOPC) were preformed. Marina Blue® DHPE was
purchased from Invitrogen, Carlsbad, CA. All other lipids were obtained from
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Avanti Polar Lipids, Alabaster, AL. A 50mL round-bottom flask was first washed
with piranha etch (a mixture of sulfuric acid and hydrochloric acid). The flask was
rinsed with distilled H2O and dried in an oven before use. Next, the determined
volumes of lipids were pipetted into a cleaned 50mL round-bottom flask
containing 1mL of chloroform. The contents were mixed manually before the
chloroform was evaporated with a Büchi RE-111 Rotovapor. Next, 1mL of
distilled H2O was added to the dried lipid mix to initiate the formation of vesicles
of varying sizes. These vesicles were allowed to hydrate overnight. The vesicles
were extruded using a LIPEXTM extruder (from Northern Lipids Inc., Burnaby,
BC, Canada) to produce a solution of uniformly sized 100nm or smaller vesicles.
These small vesicles are normally stable for a week and are necessary for vesicle
fusion to occur during bilayer deposition. Once extruded, the resulting solution of
vesicles (~1mL of solution of ~100nm lipid vesicles in H2O) was ready for
deposition on glass coverslips (solid substrate). Fisherbrand 25CIR-1 25mm
round glass coverslips were purchased from Fisher Scientific, Pittsburg, PA.
4. Deposition of SLBs
To construct a high-quality fluid bilayer, the glass substrate must be
vigorously cleaned to minimize the number of defects in the bilayer. Glass
coverslips were first sonicated and degassed in a beaker of isopropanol, rinsed in
double ionized water, and dried under nitrogen gas. Next, the glass was treated
with piranha etch, a solution of three parts 98% sulfuric acid with one part 33%
hydrochloric acid for a 10-minute interval. Piranha acid dissolves organic
molecules and leaves the glass negatively charged. Finally, the coverslips were
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thoroughly rinsed with double distilled H2O and dried under nitrogen right before
bilayer deposition. SUVs were allowed to fuse together and form a bilayer on the
glass surface. The deposition procedure took two forms (both via vesicle fusion):
Method 1
A 3:1 volume mixture of buffer solution (containing 150mM NaCl and
20mM Tris salt at pH ~7.4) to 100nm lipid-vesicle solution was prepared. SLBs
were kept in salt buffer at approximately pH 7.4, to mimic the in vivo conditions
of a eukaryotic cell. All standard salts and chemicals were purchased from SigmaAldrich, USA. Forty microliters of this lipid mixture was pipetted onto a plastic
petri dish. Next, a cleaned glass coverslip was placed over the droplet of vesicles
to expedite the vesicle fusion process and initiate bilayer formation. The droplet
of vesicles was smeared onto the glass substrate, resulting in the deposition of two
layers of lipids across the coverslip. As shown in Figure 5, to preserve the bilayer
structure, a layer of water lies between one side of the bilayer and the substrate,
while another layer of water is located in between the other side of the bilayer and
the petri dish. The dish is next submerged in the same ~7.4 pH salt buffer
solution, where the coverslip holding the SLB is mounted on a watertight
coverslip holder that allows easy access with an inverted-epifluorescence
microscope.
Method 2
In this method, a coverslip is first mounted on the microscope coverslip
holder. Next, a 30-40µL drop of the desired lipid vesicles is placed on a clean
coverslip and allowed to incubate for 10-15 minutes. Then, the coverslip is

24
submerged with buffer solution at ~7.4 pH. A SLB should form at the spot where
the drop was initially place.

5. Incubation of Aldehyde-Tagged EGFP Lipid Anchors on a SLB
Aldehyde-tagged EGFP lipid anchors were incorporated onto a SLB with
three techniques. The first technique involved passive integration, where 100µL
to 200µL of EGFP-lipids were added directly onto a previously formed SLB
composed of 2 mol percent MB DHPE and 98 mol percent DOPC. The EGFPlipid anchors were allowed to incubate and passively integrate into the SLB, for
12 to 24 hours at a time.
The second approach involved the use of detergents to help keep a larger
quantity of aldehyde-tagged EGFP lipid anchors in solution (i.e., water soluble
and away from the large aggregates). Detergents, like lipids, are amphipathic
molecules that contain a single hydrophobic acyl chain. They form micelles
around molecules and are used to gather the EGFP-lipid anchors, thereby driving
the formation of EGFP-lipid containing micelles while reducing the production of
the larger lipid aggregates. Micelles are similar to liposomes where amphipathic
molecules containing only one hydrophobic chain (as oppose to the two fatty acid
chains found in lipids), aggregate in aqueous solution with their hydrophobic tails
protected at the micelle center [Figure 2]. The EGFP-containing micelles were
directly pipetted onto a SLB and allowed to incubate for 12 to 24 hours.
The third method required the deposition of proteoliposomes that resulted
from reacting the aldehyde-tagged EGFP onto SUVs that contained the
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aminooxy-lipid. A vesicle solution containing 1 molar percent of the aminooxymodified lipids, along with 1 mol percent MB-DHPE, and 98 mol percent DOPC,
was prepared in the same fashion as described above. These aminooxy-containing
liposomes were extruded to form SUVs and allowed to react with the aldehydetagged EGFP. On average, three aldehyde-tagged EGFPs were added for one
aminooxy-modified lipid on the SUVs. The aldehyde side chains of the EGFPs
covalently bonded to the free aminooxy- groups on the preformed vesicles,
resulting in a solution of vesicles that contain the modified or tagged EGFP.
These vesicles were next separated by size exclusion chromatography to separate
the successfully coupled EGFP-proteoliposomes from the unbound or unmodified
EGFPs (i.e., non-aldehyde tagged) in solution. To improve the yield of EGFPproteoliposomes, SUVs containing 3 molar percent of the aminooxy-modified
lipids, along with 2 mol percent MB-DHPE, and 95 mol percent DOPC were
made to react with, on average, thirty aldehyde-tagged EGFPs per aminooxymodified lipid. Given the presence of non aldehyde-tagged EGFP (that has no
binding partners) in solution, the higher EGFP concentration was used to ensure
ample amounts of aldehyde-tagged EGFPs were coupled to the liposomes.

6. Size Exclusion Column Chromatography
A column was prepared with Sephacryl™ beads made from a polymer of
allyl dextran and N, N’-methylene bisacrylamide. A 133mm glass column was set
up to contain 1500µL of Sephacryl™ CL2B-300 beads in suspension. Beads had
pores of various sizes. Large molecules can easily pass around the beads and elute
out of the column, while smaller molecules must travel a longer path, through the
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bead’s pores, before coming out of the column. A sample of the EGFPEGFP
proteoliposomes was run through the column. Sephacryl™ beads were chosen
with a 50µm
m pore size, which hindered the journey of the smaller unbound or
unmodified EGFPs as significantly larger EGFP
EGFP-liposomes
liposomes were quickly filtered.
During the separation, fractions were collected after each drop, and at the end
each fraction was profiled for its contents by probing each fraction for EGFP
fluorescence with laser light. A clean separation should clearly indicate where the

Figure 13:: An intensity plot of the fractions obtained from a size exclusion column. Each
fraction was exposed to excitation photons and probed for the presence of EGFP and MB
DHPE. Fractions containing the successfully coupled aldehyde
aldehyde-tagged
tagged EGFP liposomes
displayed
yed both blue and green fluorescence.

EGFP-proteoliposomes
proteoliposomes and free EGFPs started and finished traveling through the
column [Figure
Figure 13
13]. Fractions verified to contain EGFP-proteoliposomes
proteoliposomes were
deposited via vesicle fusion and imaged with fluorescence microscopy.
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7. FRAP Analysis of Supported Lipid Bilayers
The quantitative determination of integration efficiencies as a function of
physical parameters (mostly the solution concentration of the EGFP-anchor
EGFP
construct) calls for fluorescence microscopy and fluorescence recovery after
photo-bleaching
bleaching (FRAP). Supported lipid bilayers (SLBs) were imaged with
either a Nikon
kon 60X water or oil immersion
on objectives. FRAP analysis images
were taken with an epifluorescence microscope and investigated using NIS
Elements Advance Research imaging software provided by Nikon, Japan. In
SLBs,
s, FRAP is used to study the changes in intensity by exploiting the selfself
rearranging ability of the lipid membranes to provide evidence that the
macromolecules in the bila
bilayer are functionall and mobile. A Photometrics
(Tucson,, AZ) Cascade II 1024 EMCCD camera connected to the microscope was
used to take time lapse photographs of the FRAP recovery. A strong pulse of light
was used to deactivate (“bleach”) fluorophores (i.e., the MB DHPE and EGFPFigure 14: A FRAP sequence
of a bilayer containing HisHis
tagged EGFP. The bleached
(black)
region
gradually
recovers its intensity as mobile
lipids carrying functional EGFP
move into the space. The
amount of time it takes for
strong recovery depends on the
protein-lipid
id anchor and its
membrane environment.
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lipid anchors) on a SLB. The laser light was kept on at specific wavelengths that
excited the fluorophores. With the laser turned off, active fluorophores attached to
neighboring lipids diffused into the region and effectively brightening the space
with a slightly darker shade of the original fluorescence color [Figure 14] [25].
Therefore, FRAP directly measured the percentage of fluorescence recovery and
the speed and time it took for the fluorophores to re-occupy the darkened region
[25].
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RESULTS AND DISCUSSION

1. Successful Aminooxy-Modification of Phospholipids
Nuclear magnetic resonance (NMR) was used to study the magnetic
resonance within the aminooxy-modified phospholipids in order to verify its
chemical structure. A Bruker 300MHz NMR was used to obtain 1H NMR spectra
(CDCL3) to verify the successful aminooxy-modification of lipids. The initial
spectrum in appendix B showed the initial reactants as outlined in the materials
and methods section. On the second NMR spectrum, the presence of methyl
(CH3) protons on the boc-protecting group at 1.6ppm confirmed product
formation [Appendix C]. On the last spectrum, the aminooxy-modified lipid
product is clearly deprotected, as indicated by the loss of the signal at 1.6ppm.
The rest of the spectra in appendix D were consistent with the proposed structure
identified in the reaction scheme [Appendix A].

2. Successful Attachment of EGFP to Aminooxy- Lipid
In the production of the first batch of aldehyde-tagged EGFP lipid anchors
a ~10:1 volume ratio of aminooxy-lipids to aldehyde-tagged EGFPs was reacted
with the aldehyde-tagged EGFP to ensure the limited amounts of EGFP would all
be conjugated to an aminooxy- lipid. However, the excess lipids that did not get
conjugated (to the EGFP) formed large lipid structures, as verified by
fluorescence microscopy [Figure 15]. As a result, these proteins were unable to
integrate into the membrane. However, aggregation of the usually very watersoluble EGFP is a clear indication that the protein lipidation reaction per se was

30
successful. EGFP is not a hydrophobic protein and normally wo
would
uld not seek lipids
to interact
ract and form aggregates with. Therefore, the formation of these lipid
“clumps” verified the succ
successful coupling of the aldehyde-tagged
tagged EGFPs to the
aminooxy-modified
modified lipids. The integration of individual EGFP-lipid
EGFP
constructs
would
uld have produced a uniform field of green fluorescence, because mobile
EGFP-lipid
lipid molecules would distribute evenly in the membrane.
Figure 15:: The initial reaction of
aldehyde-tagged
tagged EGFP with an
excess amount of aminooxyaminooxy lipids
resulted in large amounts of
“clumping,”
where
uncoupled
aminooxy- lipids would form
for larger
lipid structures around the modified
EGFP-lipid
lipid
anchor
constructs.
Aggregation
supported
the
successful reaction of the aldehydealdehyde
tagged EGFP to the aminooxyaminooxy
lipid,
since
EGFP
is
not
hydrophobic in nature and would
therefore not collect around lipids.
lip
As a result, the aldehyde-tagged
aldehyde
EGFPs must have successfully
reacted with the aminooxyaminooxy lipids
and acquired some of the lipids’
hydrophobic nature.

3. Fluorescence Analysis of SLB fro
from Proteoliposomes Deposition
The results of the protein integration to a supported lipid bilayer (SLB)
were obtained by examining the fluidity of the protein and the lipid environment.
To that end, membrane integrity, as well as protein and lipid motility, were
investigated using fluorescence recovery after photo
photo-bleaching
hing (FRAP). After the
aldehyde-tagged
tagged EGFP reacted with the aminooxy
aminooxy-lipid
lipid containing small
unilamellar vesicles (SUVs), a bilayer was made from these proteoliposomes.
The final proteoliposo
proteoliposomes
mes contained about 1 mol percent MB DHPE, 98 mol
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percent DOPC, and 1 mol percent of aminooxy-modified
modified lipid anchors with
aldehyde-tagged
tagged EGFP bound to some fraction of them
them. The blue fluorescent MBMB
DHPE was used to check the integrity of the bilayer without
ut having to compete
with
ith EGFP’s green fluorescence. A perfect and intact bilayer displays a uniform
field of blue before and after GFP integration. FRAP analysis on the blue channel
displayed an intact bilayer, with few visible defects
defects,, that recovered well [Figure

Figure 16:: A FRAP time sequence of the recovery in intensi
intensity
ty on the blue channel. Smooth
recovery indicated an intact bilayer with mobile MB DHPE lipids.

16]. In figure 16, FRAP analysis images were taken within 5 to 10 seconds apart.
Inspection on the green channel showed noticeable recovery over an extended
period of time (~22 to 5 hours) [Figure 17]. This slow recovery may be due to the
presence of unbound and unmodified EGFP in solution. Free EGFP was found to
have likely bonded to the glass substrate and remained immobile,
immobile hindering the
lateral motion of its neighboring lipids and thereby increasing the time it takes for
lipids carrying functional EGFP to travel into the bleached zone. Furthermore, the
dark silhouette that remained in the last FRAP image in Figure 17, was likely due
to permanently bbound
ound EGFP on the glass, that had been bleached and then
essentially occupied the space where mobile lipids carrying aldehyde-tagged
EGFP were trying to enter
enter.. A comparison of the normalized intensity profiles of
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the first and last image in the EGFP FRAP sequence indicated an
a expected
increase in the intensity of the bleached region from the first frame to the last
[Figure 15]. The
he obvious recovery in green intensity demonstrated the presence of
mobile EGFP-lipids
lipids and the overall successfu
successfull incorporation of the aldehydealdehyde
tagged EGFP aminooxy
aminooxy- lipid anchors into the SLB.

Figure 17: A FRAP sequence of aldehyde tagged EGFP + Aminooxy
Aminooxy-modified
modified Lipid anchors
on a SLB. The intensity plot tracks the increasing change in intensity from the first time
capture to the last frame (over a period of 5 hours) as mobile EGFP
EGFP-carrying
carrying lipids diffuse into
the bleached region.

4. Size Exclusion Purification of Proteoliposomes
The
he noticeable presence of unbound or unmodified (i.e., non-aldehydenon
tagged) EGFP influenced the decision to add a purification step after the
aldehyde-tagged
tagged EGFPs were reacted with the aminooxy
aminooxy-containing
containing liposomes.
Separation of the EGFP
EGFP-proteoliposomes was successful and produced a good
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range of fractions that contained proteoliposomes. From Figure 13, the aldehydetagged EGFP proteoliposomes were likely found in fractions 5 through 11 where
intensity measurements revealed sufficient amounts of blue and green signal.
Fractions 12 through 19 displayed only high amounts of green signal giving
evidence that only unbound aldehyde-tagged or unmodified EGFPs were present
in these fractions [Figure 13]. However, deposition of the proteoliposomes in
fractions 5 through 11 produced SLBs with too little green fluorescence for a
FRAP analysis. For the next reaction, a higher concentration of aminooxy-lipids
will be added to the initial vesicle production, in addition to adding more
aldehyde-tagged EGFP to the reaction.

5. A Comparison: The Aldehyde Tag Modification vs. Current Protein
Attachment Strategies
In the development of biomimetic lipid surfaces, the aldehyde tag method
offers unprecedented freedom to site-specifically modify proteins at any location
along its peptide structure, thereby controlling the site where the protein will
couple with a lipid anchor. As mentioned above, current protein attachment
strategies such as the addition of a GPI lipid anchor may be added only at a
protein’s C terminus and the His-tag may be applied only at both the C and N
terminus. As a result, these two techniques only allow a lipid anchor to bind at
one or two sites on the protein, respectively. In the biotin-streptavidin method,
biotinylation is non-site specific resulting in the binding of biotin on various
places on a protein. Therefore, the biotin-streptavidin method remains difficult to
predict and control how the modified protein will attach on the lipid bilayer.
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The His-tag and biotin-streptavidin methods are also hampered by the lack
of diverse, and commercially available, lipid anchor motifs. In the aldehyde tag
method, the aminooxy-modification may be performed on any commercially
available phosphatidylethanolamine (PE) to generate diverse lipid anchors. PE
phospholipids with varying acyl chains are commercially available from many
vendors such as Avanti Polar Lipids (Alabaster, AL). Therefore, an aldehydetagged protein may bind to a variety of different phospholipid anchors with
different fatty acid chains. This versatility promotes the development of diverse
bilayers with unique lipid compositions for applications such as phase separation
studies.
The His-tag and biotin-streptavidin methods also require modified proteins
(i.e., His-tagged or biotinylated proteins) to compete for single substrates (e.g.,
nickel or streptavidin) on the membrane surface. If multiple modified-proteins
were deposited on to a bilayer, they would compete for the same binding partners
on the bilayer. Therefore, competitive binding on the membrane surface prohibits
the production of biomimetic membranes with pre-determined concentrations for
each type of modified protein. On the other hand, in the aldehyde tag method,
because aldehyde-tagged proteins are reacted on small unilamellar vesicles
(SUVs) containing aminooxy- lipids prior to SLB formation, multiple aldehydetagged proteins my be reacted to different solutions of aminooxy- containing
SUVs generating SUVs with the same lipid composition but varying aldehydetagged proteins. Next these assorted SUVs may be combined (at specific volume
ratios) through vesicle fusion, and deposit into a supported lipid bilayer. Table 1
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below summarizes the advantages of the different protein attachment strategies
that are currently used to attach proteins on biomimetic membranes:
Table 1: A summary of the advantages and disadvantages of current membrane protein
attachment strategies

Protein
Attachment
Strategy

C Terminus
Modification

N Terminus
Modification

GPI



---

Site-specific
Modification
Along the
Protein
---

His Tag +
Nickel
Biotin +
Streptavidin
Aldehyde Tag





---

---





---

---









Diversity in
Lipid Anchor
Motifs
---
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CONCLUSION AND FUTURE WORK
Biological membranes not only provide a protective barrier for cells and
their intracellular compartments, but also host all the machinery for cellular
communication and transport across the bilayer that allows cellular function to
proceed. Due to the high level of specificity in cellular signaling and trafficking,
the correct arrangement and orientation of receptor proteins is integral to
accurately managing chemical recognition. The aldehyde tag based method of
covalent lipidation developed in this study permits protein modifications with an
unrivaled freedom and accuracy that stretches beyond the biofunctionaliztion of
biomimetic membranes. By varying the site of lipidation to include the aldehyde
tag on the amino (N-) terminus or along the middle body of the EGFP, aldehyde
tag expression at different areas of the EGFP, along with their effects on protein
lipidation and membrane integration, will be explored in future work. In addition,
by using a variety of anchoring lipid motifs, the dependence of the protein
integration on the chemical structure of the lipid will be studied. By varying the
chemical structure of the lipid anchors to reflect those with known phase
separation (lipid arrangement) behavior, the ability of proteins (lipidated using the
aldehyde-tag strategy) to partake in more complex membrane dynamics will be
evaluated. Depending on the specific lipid motif, if the membrane system
undergoes a phase transition induced by temperature change, the EGFP should
redistribute in the membrane in expected patterns consistent with its lipid
composition. Extending the aldehyde tag to lipidate antibodies would be a step
towards defining sensory and drug delivery applications. Once the integration
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technique is refined, different proteins may be aldehyde-tagged and lipidated for
membrane integration and provide steps towards advancing biological, medical
and biotechnological applications.
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APPENDICES
Appendix A: Reaction Schematics for the Aminooxy-Modification
Modification of a Lipid and Subsequent
Conjugation to a Aldehyde
Aldehyde-Tagged Protein
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Appendix B: 1H NMR Spectra of the Starting Materials in the Aminooxy-Modification
Modification Reaction
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Appendix C: 1H NMR Spectra of the Protected Lipids in the Aminooxy-Modification
Modification Reaction
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Appendix D: 1H NMR Spectra of the De-protected Lipids in the Aminooxy-Modification
Aminooxy
Reaction
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CAPSTONE SUMMARY
A distinguishing feature of cellular life is the ability for animal cells to
communicate, exchange, and process biochemical information. A variety of
important chemical recognition events transpire on the cell membrane, which
protects the cell’s inner environment. Proteins, such as antibodies and receptor
proteins, attached to the membrane surface play a key role in the essential
chemical recognition and information exchange within a cell or with the exterior
environment outside the cell. Because of the high level of specificity in
biochemical recognition, artificial membranes that interface with living cells must
be developed in a way that allows proteins to freely reorganize themselves on the
membrane surface. Therefore, efforts in maximizing the effectiveness of cell
surface functionality in synthetic or artificial membrane systems is important in
the advancement of biomedicine, biotechnology, and basic science.
Human and animal cells contain a variety of lipid membrane-enclosed
organelles – most importantly a nucleus that carries the organism’s genetic
information. The entire exterior is protected by a cell membrane, composed of
phospholipids, which are amphipathic molecules containing a hydrophilic (waterloving) head region and two hydrophobic (water-fearing) fatty acid chains. In
aqueous solution, the lipids form closed three-dimensional structure, called
liposomes or vesicles, where all the hydrophilic heads facing out and the
hydrophobic tails facing in. This configuration enforces a “like attracts like”
phenomenon that keeps all the hydrophilic heads and hydrophobic tails facing
their preferred environments. The wall of a liposome is therefore a continuous
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bilayer where two leaflets of lipids situate on top of each other in the
configuration mentioned above. At the surface, a cell is essentially a liposome
with specialized organelles and membranes carrying out its life-sustaining
processes. Therefore, many simplified model membrane systems or biomimetic
membranes have been synthesized to study certain cell surface interactions and
properties by mimicking sections or aspects of the cell membrane.
Much like living cell membranes, biomimetic membrane systems often
require specific proteins to be attached, via e.g., a lipid anchor on its surface, in
order to carry out a specialized function. Lipids and proteins must be able to
freely diffuse and rearrange across the surface of the bilayer. In many cases of
cellular signaling, the coming together of multiple protein receptors is required for
the proper signal to be created. However, current protein attachment strategies
have been limited by both the site where a protein may be modified to attach to a
lipid anchor and the types of commercially available lipids that may be coupled to
a protein. For example, the histidine + nickel interaction has been exploited in the
production of biomimetic lipid surfaces. A series of histidine amino acid residues
are linked to either the C or N terminus (i.e., the two poles of a protein’s
structure) and allowed to bind to nickel atoms attached on lipid anchors on a
bilayer. However, since the His-tag may only be added to the two ends of a
protein it does not permit proteins to be anchored to a lipid from its side or some
location along the body of the protein. Furthermore, only one lipid anchor with a
nickel atom on its head group is commercially available, thereby severely limiting
the production of diverse membrane compositions.
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With the recently developed aldehyde tag modification, a protein may be
modified at virtually any location along its amino acid chain (the pre-protein
structure) to bear a reactive aldehyde group that may bind to an aldehyde-specific
binding partner including one of many modified lipid anchors. Lipid anchors
modified to have an aminooxy- group may covalently bind with an aldehydetagged protein for subsequent incorporation into a biomimetic bilayer.
In this study, the aldehyde tag technology was incorporated into an
enhanced fluorescence protein (EGFP) and later coupled to an aminooxymodified lipid anchor for deposition onto a supported lipid bilayer. A supported
lipid bilayer is a biomimetic membrane system that allows the easy study of
membrane surface assembly and structure with microscopy techniques. By using
EGFP, which fluoresces green when exposed to the right, blue excitation light, the
successful incorporation of the aldehyde-tagged EGFP lipid anchors will produce
bilayers that can be imaged and examined for fluidity with a fluorescence
microscope.
A special six-amino-acid consensus sequence is first inserted into the C
terminus EGFP’s amino acid chain. Next a formylglycine-generating enzyme
(FGE) reads this sequence and converts the cysteine amino acid (that is in the
sequence), into a formylglycine, which contains the aldehyde group. This
consensus sequence offers the site-specific introduction of an aldehyde group, i.e.,
wherever the consensus sequence is inserted, the protein will be translated into its
final structure with the aldehyde group at that location. Next commercially
available phosphatidylethanolamine (PE) lipid anchors with varying fatty acid
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chains may be aminooxy- modified and coupled with the tagged EGFP. This
permits the freedom to generate assorted biomimetic membranes with unique lipid
compositions for various biological studies and applications. In the experiment,
aldehyde-tagged EGFPs were coupled/reacted on to small lipid vesicles
containing aminooxy- lipids. The resulting solution of EGFP proteoliposomes
were allowed to fuse, through a process called vesicle fusion, and flatten into a
bilayer on glass substrate.
Once a bilayer was formed, fluorescence recovery after photo-bleaching
(FRAP) was used to analyze the mobility of the EGFP lipid anchors. In a FRAP
study, a strong pulse of light is used to deactivate (“bleach”) the EGFP leaving a
dark region of space, while over time, active EGFP attached to neighboring lipids
will begin to diffuse into the region and effectively fill it with a darker shade of
the original fluorescence color. FRAP studies of the bilayers revealed successful
recovery supported the EGFP-lipid anchor integration. However, the presence of
extra unbound or free non-aldehyde tagged EGFP, during the coupling reaction,
may have interfered with the bilayer deposition process. These excess EGFP
would permanently bind to the glass, bleach, and remain immobile, as
neighboring lipids carrying functional EGFP must diffuse around them. This issue
will be addressed with additional filtering to separate out the successfully reacted
EGFP proteoliposomes before bilayer deposition.
The successful FRAP analyses proved that the aldehyde tag may be used
to couple proteins to lipid anchors while remaining functional and mobile when
attached to a supported lipid bilayer. For the development of biomimetic
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membranes, effectively any protein may be aldehyde tagged from any position to
attach to a lipid anchor on a bilayer. In future work, by introducing the aldehyde
tag at different sites along the EGFP, the effects of location on the successful
aldehyde tag modification may be examined. Furthermore, by tagging a different
protein, such as an antibody, sensory applications may be further explored.
Therefore, the aldehyde tag method provides a versatile and powerful way to
modify proteins not only for attachment to lipid anchors but also for many other
biological studies.

